Inside Covid-19: SA link in AI design to assist battle virus; Lessons from the US’s record setting 2nd wave. Ep 54

Inside Covid-19: SA link in AI design to assist battle virus; Lessons from the US’s record setting 2nd wave. Ep 54

In Episode 54 of Inside Covid-19, some professional insight (and good news) as SA strikes number 5 among the world’s brand-new daily infection table; a worldwide South African tech master breaks brand-new ground on the coronavirus with an agent-based expert system design; there’s bad news for dining establishment owners worldwide as a minimum of 25%are expected to never ever re-open; and another dazzling investigation by our partners at the Wall Street Journal– this time into why infections in the hard-hit USA are back at new record levels– and what other countries like South Africa can gain from it.– Alec Hogg

In today’s Covid-19 headings:

  • With new infections having established an everyday base of over 6,000, South Africa is now entrenched in the international leading five on new coronavirus infections. Down on Saturday’s peak of over 7,000, Monday’s 6,130 brand-new cases took the nation’s overall infections to more than 144,000 An additional 73 deaths pushed the overall over 2,500
  • Internationally, overall infections are now 10.5 m with deaths of 510,000 A second wave in the USA has taken brand-new infections to a fresh peak of 47,000 last Friday. Monday’s 44,700 brand-new infections was the 2nd highest of any one day overall cases now over 2.7 m and mortalities at 130000.
  • Some good news from a Johannesburg business as a home grown Covid-19 testing kit promises to enter one of South Africa’s greatest spaces in the nationwide fight against the virus.
  • One of US president Donald Trump’s favourite anti-coronavirus drugs, hydroxochloroquine, is discovering some favour once again. In spite of findings released 2 months ago in the Journal of the American Medical Association (JAMA), that hydroxychloroquine, when utilized to deal with Covid-19, caused cardiac arrhythmias, a significant international trial of the drug is about to resume. British regulators have actually approved the resumption of the so-called COPCOV trial involving 40,000 healthcare and other at-risk workers. The stop-start trial, the biggest and therefore the most crucial, was halted when inconclusive or red-flag results from smaller-scale trials left regulators in the UK and the U.S.A. anxious. You’ll find more about this story on Biznews.com

( Checked Out 81 times, 81 sees today)

Cyril Ramaphosa: The Audio Biography

Listen to the story of Cyril Ramaphosa’s rise to presidential power, told by our extremely own Alec Hogg.

Get the Audiobook

Narration by Alec Hogg

Read More